Compare ITW & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITW | BMY |
|---|---|---|
| Founded | 1912 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.0B | 113.5B |
| IPO Year | 1994 | 2006 |
| Metric | ITW | BMY |
|---|---|---|
| Price | $290.36 | $63.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 15 |
| Target Price | ★ $263.45 | $61.73 |
| AVG Volume (30 Days) | 1.3M | ★ 11.8M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | 2.42% | ★ 4.38% |
| EPS Growth | N/A | ★ 178.46 |
| EPS | ★ 5.50 | 2.93 |
| Revenue | $14,768,000,000.00 | ★ $48,194,000,000.00 |
| Revenue This Year | $4.27 | N/A |
| Revenue Next Year | $3.44 | N/A |
| P/E Ratio | $52.90 | ★ $22.06 |
| Revenue Growth | ★ 3.17 | N/A |
| 52 Week Low | $238.82 | $42.52 |
| 52 Week High | $303.16 | $68.10 |
| Indicator | ITW | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 57.22 | 58.70 |
| Support Level | $244.24 | $56.46 |
| Resistance Level | $301.87 | $68.10 |
| Average True Range (ATR) | 6.72 | 1.79 |
| MACD | -0.78 | -0.22 |
| Stochastic Oscillator | 42.39 | 33.48 |
Founded in 1912, Illinois Tool Works has become a diversified industrial manufacturer through acquisitions and innovations that follow customer needs. ITW operates through seven business segments, with no segment representing more than one-fifth of revenue. ITW's automotive OEM segment sells vehicle components; its food equipment segment sells commercial kitchen appliances; its test and measurement and electronics segment sells inspection and analysis equipment; its welding segment sells welding equipment and consumables; its polymers and fluids segment sells industrial and consumer adhesives, solvents, and coatings; its construction products segment sells building fasteners and tools; and its specialty products segment sells medical, packaging, HVAC, and airport ground equipment.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.